[{"StockholdersEquityConverted_0_Q1_USD":10663200000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":151900000.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_1_Q1_USD":769000000.0,"EarningsPerShareDiluted_1_Q1_USD":2.69,"StockholdersEquity_0_Q1_USD":10682200000.0,"NetIncomeLossConverted_1_Q1_USD":404600000.0,"Assets_0_Q1_USD":23854700000.0,"RevenuesConverted_1_Q1_USD":2694000000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":152300000.0,"EarningsPerShareBasic_1_Q1_USD":2.7,"Ticker":"BIIB","CIK":"875045","name":"BIOGEN INC.","OfficialName":"Biogen Inc. Common Stock","form":"10-Q","period":"20210331","fy":"2021.0","fp":"Q1","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"32775642095.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"SP500","filed":"20210422"}]